Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited T14.SI Stock
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Price Chart
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited T14.SI Financial and Trading Overview
Contents
- Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Price Chart
- Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited T14.SI Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
- Q&A For Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
| Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock price | 2.02 USD |
| Previous Close | 2.07 USD |
| Open | 2.09 USD |
| Bid | 2.19 USD x 0 |
| Ask | 2.2 USD x 0 |
| Day's Range | 2.09 - 2.22 USD |
| 52 Week Range | 0.93 - 2.44 USD |
| Volume | 321.3K USD |
| Avg. Volume | 473.86K USD |
| Market Cap | 4.36B USD |
| Beta (5Y Monthly) | 0.972413 |
| PE Ratio (TTM) | 11.578948 |
| EPS (TTM) | 0.18 USD |
| Forward Dividend & Yield | 0.16 (7.75%) |
| Ex-Dividend Date | May 26, 2023 |
| 1y Target Est | N/A |
T14.SI Valuation Measures
| Enterprise Value | -1243292160 USD |
| Trailing P/E | 11.578948 |
| Forward P/E | 27.500002 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.51214886 |
| Price/Book (mrq) | 0.24641576 |
| Enterprise Value/Revenue | -0.146 |
| Enterprise Value/EBITDA | -1.313 |
Trading Information
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock Price History
| Beta (5Y Monthly) | 0.972413 |
| 52-Week Change | 83.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.44 USD |
| 52 Week Low | 0.93 USD |
| 50-Day Moving Average | 2.14 USD |
| 200-Day Moving Average | 1.38 USD |
T14.SI Share Statistics
| Avg. Volume (3 month) | 473.86K USD |
| Avg. Daily Volume (10-Days) | 215.57K USD |
| Shares Outstanding | 200M |
| Float | 426.62M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.059% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.12 |
| Trailing Annual Dividend Yield | 54.10% |
| 5 Year Average Dividend Yield | 461.00% |
| Payout Ratio | 0.3652 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 12.48% |
| Operating Margin (ttm) | 9.80% |
| Gross Margin | 41.85% |
| EBITDA Margin | 11.12% |
Management Effectiveness
| Return on Assets (ttm) | 5.17% |
| Return on Equity (ttm) | 15.67% |
Income Statement
| Revenue (ttm) | 8.51B USD |
| Revenue Per Share (ttm) | 11.05 USD |
| Quarterly Revenue Growth (yoy) | 14.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 947.26M USD |
| Net Income Avi to Common (ttm) | 1.06B USD |
| Diluted EPS (ttm) | 0.19 |
| Quarterly Earnings Growth (yoy) | 100.79% |
Balance Sheet
| Total Cash (mrq) | 3.46B USD |
| Total Cash Per Share (mrq) | 4.47 USD |
| Total Debt (mrq) | 606.7M USD |
| Total Debt/Equity (mrq) | 8.75 USD |
| Current Ratio (mrq) | 2.22 |
| Book Value Per Share (mrq) | 8.928 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 785.39M USD |
| Levered Free Cash Flow (ttm) | 679.29M USD |
Profile of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
| Country | Singapore |
| State | N/A |
| City | Tianjin |
| Address | Zhong Xin Mansion |
| ZIP | 300193 |
| Phone | 86 22 2702 0892 |
| Website | https://www.zhongxinp.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 4913 |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.
Q&A For Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
What is a current T14.SI stock price?
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited T14.SI stock price today per share is 2.02 USD.
How to purchase Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock?
You can buy T14.SI shares on the SES exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited?
The stock symbol or ticker of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is T14.SI.
Which industry does the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited company belong to?
The Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited have in circulation?
The max supply of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited shares is 1.43B.
What is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Price to Earnings Ratio (PE Ratio)?
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited PE Ratio is 11.22222100 now.
What was Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited earnings per share over the trailing 12 months (TTM)?
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited EPS is 0.18 USD over the trailing 12 months.
Which sector does the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited company belong to?
The Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited sector is Healthcare.